|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3638696 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18732064.3 |
| Date of filing the European patent application | 2018-06-18 | |
| (97) | Date of publication of the European application | 2020-04-22 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-06 |
| (46) | Date of publication of the claims translation | 2024-06-25 |
| (86) | Number | PCT/EP2018/066144 |
| Date | 2018-06-18 |
| (87) | Number | WO 2018/229303 |
| Date | 2018-12-20 |
| (30) | Number | Date | Country code |
| 201709677 | 2017-06-16 | GB |
| (72) |
LEUPIN, Nicolas , BE
VAN ROMPAEY, Luc , BE
DE HAARD, Hans , BE
OCHSENBEIN, Adrian , CH
RIETHER, Carsten , CH
|
| (73) |
argenx BV ,
Industriepark-Zwijnaarde 7, 9052 Zwijnaarde (Ghent),
BE
University of Bern , Verwaltungsdirektion Hochschulstrasse 6, 3012 Bern, CH |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Prieš CD70 nukreipto antikūno ARGX-110 panaudojimas ūminei mieloidinei leukemijai gydyti |
| USE OF ANTI CD70 ANTIBODY ARGX-110 TO TREAT ACUTE MYELOID LEUKAEMIA |
| Payment date | Validity (years) | Amount | |
| 2025-06-02 | 8 | 185.00 EUR |
| 2026-06-18 |